Rmr Wealth Builders Oramed Pharmaceuticals Inc. Transaction History

Rmr Wealth Builders

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.34 - $14.59 $19,182 - $33,557	-2,300 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.22 - $11.33 $1,477 - $3,965	350 Added 17.95%	2,300 $23,000
Q4 2020 Feb 26, 2021	BUY	$2.48 - $4.64 $4,836 - $9,048	1,950 New	1,950 $8,000
Q3 2020 Nov 13, 2020	SELL	$2.58 - $4.16 $1,161 - $1,872	-450 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$2.43 - $5.74 $1,093 - $2,583	450 New	450 $2,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.